Cutting edge: Interactions through the IL-10 receptor regulate autoimmune diabetes

Journal of Immunology

Volumn 167, Issue 11, 2001, Pages 6087-6091

  Phillips, J M ^a   Parish, N M ^a   Drage, M ^a   Cooke, A ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 10 RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNE DISEASE; CELL ACTIVATION; CONTROLLED STUDY; DIABETES MELLITUS; DIABETOGENESIS; DISEASE ASSOCIATION; GENE CONTROL; GENE REARRANGEMENT; IMMUNOREGULATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INTERACTION; SPLEEN CELL; T LYMPHOCYTE;

EID: 0035575760     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.11.6087     Document Type: Article

References (35)

1. Suppressor T cells in experimental autoimmune haemolytic anaemia
2. Spontaneous thyroiditis in thymectomized and irradiated Wistar rats
3. Murine thyroiditis induced by neonatal thymectomy
4. Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease
5. Mechanisms of autoimmunity
6. The thymus contains a high frequency of cells that prevent autoimmune diabetes on transfer into prediabetic recipients
7. + T cells
8. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis
9. + regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4
10. Breeding of a non-obese, diabetic strain of mice
11. Following a diabetogenic T cell from genesis through pathogenesis
12. + islet-specific T cell clone
13. Genetic control of diabetes progression
14. Mechanism underlying counterregulation of autoimmune diabetes by IL-4
15. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice
16. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
17. Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor α-chains (CD25): Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases
18. + T cells inhibit both the induction and effector function of autoreactive T cells and represent a unique lineage of immunoregulatory cells
19. Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation
20. + naturally anergic and suppressive T cells: Induction of autoimmune disease by breaking their anergic/suppressive state
21. + regulatory cells that control intestinal inflammation
22. - subpopulations
23. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation
24. IL-10 inhibits macrophage activation and proliferation by distinct signaling mechanisms: Evidence for Stat3-dependent and -independent pathways
25. IFN-α and IL-10 induce the differentiation of human type 1 T regulatory cells
26. Tolerance induction as a therapeutic strategy for the control of autoimmune endocrine disease in mouse models
27. Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes
28. IL-10 inhibits cytokine production by activated macrophages
29. In vitro inhibition of insulin release by blood mononuclear cells from insulin-dependent diabetic and healthy subjects: Synergistic action of IL-1 and TNF
30. Recombinant human IL-10 prevents the onset of diabetes in the nonobese diabetic mouse
31. A noncytolytic IL-10/Fc fusion protein prevents diabetes, blocks autoimmunity, and promotes suppressor phenomena in NOD mice
32. Suppression of T(h)1 cell activation and prevention of autoimmune diabetes in NOD mice by local expression of viral IL-10
33. Prevention of adoptively transferred diabetes in nonobese diabetic mice with IL-10-transduced islet-specific Th1 lymphocytes: A gene therapy model for autoimmune diabetes
34. Production of interleukin 10 by islet cells accelerates immune-mediated destruction of β cells in nonobese diabetic mice
35. Pinpointing when T cell costimulatory receptor CTLA-4 must be engaged to dampen diabetogenic T cells